Granahan Investment Management - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 368 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2024. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q2 2024$6,341,147
+83.4%
92,585
+85.3%
0.25%
+109.9%
Q1 2024$3,458,20149,9740.12%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q2 2024
NameSharesValueWeighting ↓
Deep Track Capital, LP 1,548,252$98,035,3174.54%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,198,971$75,918,8444.06%
SILVERARC CAPITAL MANAGEMENT, LLC 198,723$12,583,1403.89%
DCF Advisers, LLC 107,157$6,785,1813.58%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,856$11,182,6053.40%
Vahanian & Associates Financial Planning Inc. 15,217$963,5403.05%
Bellevue Group AG 3,201,800$202,737,9762.89%
TANG CAPITAL MANAGEMENT LLC 300,000$18,996,0002.80%
Nicholas Investment Partners, LP 499,503$31,628,5302.16%
Hood River Capital Management LLC 839,130$53,134,0001.58%
View complete list of INTRA CELLULAR THERAPIES INC shareholders